Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Brendon L. Neuen(The George Institute for Global Health), Lesley A. Inker(Tufts Medical Center), Jack F.M. Wetzels(Radboud University Nijmegen), Tom Greene(University Medical Center Groningen), Hiddo J.L. Heerspink(University Medical Center Groningen), Christoph Wanner(Universitätsklinikum Würzburg), Mark Woodward(UNSW Sydney), Marián Goicoechea(Hospital General Universitario Gregorio Marañón), Manuel Praga(Universidad Complutense de Madrid), Annalisa Perna(Mario Negri Institute for Pharmacological Research), Edward F. Vonesh(Northwestern University), Julia B. Lewis, Hocine Tighiouart(Tufts University), Di Xie(Xuzhou Medical College), Tak Mao Chan(Chinese University of Hong Kong), Francesco Locatelli(University of Modena and Reggio Emilia), Fernando C. Fervenza(Mayo Clinic), Enyu Imai(Takara (Japan)), William G. Herrington(Oxford Health NHS Foundation Trust), Juhi Chaudhari(Tufts Medical Center), Bart Maes(AZ Delta), Ronald D. Perrone(Tufts Medical Center), Tazeen H. Jafar(Apple (Israel)), Francesco Paolo Schena(University of Bari Aldo Moro), Jürgen Floege(RWTH Aachen University), Shiyuan Miao(Tufts Medical Center), Philip Kam‐Tao Li(Hospital Authority)
Cited by 29
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k